Literature DB >> 29942980

Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.

TianHong Zhang1, LiHua Xu2, YingYing Tang2, HuiRu Cui2, XiaoChen Tang2, YanYan Wei2, Yan Wang2, Qiang Hu2, ZhenYing Qian2, XiaoHua Liu2, ChunBo Li2,3, JiJun Wang4,5,6.   

Abstract

Our previous study has found that a long duration of untreated prodromal symptoms (DUPrS) does not increase the conversion risk to psychosis in individuals with attenuated psychosis syndrome (APS). However, whether a long DUPrS will lead to other poor outcomes remains unknown. The purpose of this study was to analyse the association between the DUPrS and outcomes (symptomatic and functional recovery) in APS population. A post hoc analysis was performed in 391 individuals with APS as identified by the structured interview. APS subjects had follow-up interviews every 6 months for 2 years following diagnosis. Poor functional outcome was defined as a Global Assessment of Functioning (GAF) score less than 60 at the time of follow-up. Poor symptomatic outcome was defined as at least one of the positive symptoms rated scores of 3 or higher. A post hoc analysis was performed in 391 individuals with APS as identified by the structured interview. APS subjects had follow-up interviews every 6 months for 2 years following diagnosis. Poor functional outcome was defined as a Global Assessment of Functioning (GAF) score less than 60 at the time of follow-up. Poor symptomatic outcome was defined as at least one of the positive symptoms rated scores of 3 or higher. Of total 391 individuals, 334 were followed up for 2 years to assess clinical outcome, 82 (24.6%) had shown conversion to psychosis, 79 (23.7%) met the criteria of poor functioning outcome, and 145 (43.4%) met the criteria of poor symptomatic outcome. A significant correlation between GAF scores and DUPrS was observed in the non-converter group, but not in the converters. Individuals with APS who had a longer DUPrS were correlated with poorer functional outcome. However, it was not correlated with poorer symptomatic outcome. While a longer DUPrS was not related to poor symptomatic outcome, it was significantly related to poor functional outcome. Our findings highlight the importance of reducing DUPrS to decrease future functional impairment in populations at risk for psychosis.

Entities:  

Keywords:  Clinical high risk; Duration of untreated prodromal symptoms; Duration of untreated psychosis; Outcome; Prodromal psychosis

Mesh:

Year:  2018        PMID: 29942980     DOI: 10.1007/s00406-018-0917-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  22 in total

1.  Global Assessment of Functioning (GAF): properties and frontier of current knowledge.

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

2.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome.

Authors:  Wenche Ten Velden Hegelstad; Tor K Larsen; Bjørn Auestad; Julie Evensen; Ulrik Haahr; Inge Joa; Jan O Johannesen; Johannes Langeveld; Ingrid Melle; Stein Opjordsmoen; Jan Ivar Rossberg; Bjørn Rishovd Rund; Erik Simonsen; Kjetil Sundet; Per Vaglum; Svein Friis; Thomas McGlashan
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 4.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

5.  Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis.

Authors:  P Fusar-Poli; A Meneghelli; L Valmaggia; P Allen; F Galvan; P McGuire; A Cocchi
Journal:  Br J Psychiatry       Date:  2009-02       Impact factor: 9.319

6.  Understanding the relationship between duration of untreated psychosis and outcomes: A statistical perspective.

Authors:  Ailish Hannigan; Norma Bargary; Anthony Kinsella; Mary Clarke
Journal:  Early Interv Psychiatry       Date:  2017-06-14       Impact factor: 2.732

7.  Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis.

Authors:  Myong-Wuk Chon; Tae Young Lee; Sung Nyun Kim; Min Jung Huh; Hye Youn Park; Cho Rong Lee; Na Young Shin; Jun Soo Kwon
Journal:  Schizophr Res       Date:  2015-01-28       Impact factor: 4.939

8.  A critique of the "ultra-high risk" and "transition" paradigm.

Authors:  Jim van Os; Sinan Guloksuz
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

9.  Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.

Authors:  Ricardo E Carrión; Docia Demmin; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Todd Lencz; Christoph U Correll; Barbara A Cornblatt
Journal:  J Psychiatr Res       Date:  2016-06-26       Impact factor: 4.791

10.  Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up.

Authors:  Stephen F Austin; Ole Mors; Rikke Gry Secher; Carsten R Hjorthøj; Nikolai Albert; Mette Bertelsen; Heidi Jensen; Pia Jeppesen; Lone Petersen; Lasse Randers; Anne Thorup; Merete Nordentoft
Journal:  Schizophr Res       Date:  2013-08-08       Impact factor: 4.939

View more
  4 in total

1.  Psychiatrists are experts when it comes to missing boats. Will prevention be the next one?

Authors:  Celso Arango
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-12       Impact factor: 5.270

2.  Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2).

Authors:  GuiSen Wu; RanPiao Gan; ZhiXing Li; LiHua Xu; XiaoChen Tang; YanYan Wei; YeGang Hu; HuiRu Cui; HuiJun Li; YingYing Tang; Li Hui; XiaoHua Liu; ChunBo Li; JiJun Wang; TianHong Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-24       Impact factor: 2.570

3.  Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals.

Authors:  LiHua Xu; Mei Zhang; ShuQin Wang; YanYan Wei; HuiRu Cui; ZhenYing Qian; YingChan Wang; XiaoChen Tang; YeGang Hu; YingYing Tang; TianHong Zhang; JiJun Wang
Journal:  Front Psychiatry       Date:  2021-11-10       Impact factor: 4.157

4.  Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.

Authors:  Lorna Staines; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas
Journal:  BMC Psychiatry       Date:  2021-07-07       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.